102 related articles for article (PubMed ID: 15823274)
1. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice.
Bengtsson E; To F; Grubb A; Håkansson K; Wittgren L; Nilsson J; Jovinge S
Atherosclerosis; 2005 May; 180(1):45-53. PubMed ID: 15823274
[TBL] [Abstract][Full Text] [Related]
2. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
[TBL] [Abstract][Full Text] [Related]
3. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
Boisvert WA; Black AS; Curtiss LK
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):525-30. PubMed ID: 10073953
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice.
Sukhova GK; Wang B; Libby P; Pan JH; Zhang Y; Grubb A; Fang K; Chapman HA; Shi GP
Circ Res; 2005 Feb; 96(3):368-75. PubMed ID: 15653570
[TBL] [Abstract][Full Text] [Related]
5. Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow.
Van Eck M; Herijgers N; Vidgeon-Hart M; Pearce NJ; Hoogerbrugge PM; Groot PH; Van Berkel TJ
Atherosclerosis; 2000 May; 150(1):71-80. PubMed ID: 10781637
[TBL] [Abstract][Full Text] [Related]
6. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice.
Jormsjö S; Wuttge DM; Sirsjö A; Whatling C; Hamsten A; Stemme S; Eriksson P
Am J Pathol; 2002 Sep; 161(3):939-45. PubMed ID: 12213722
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
9. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
10. Elastin- and collagen-rich human carotid plaques have increased levels of the cysteine protease inhibitor cystatin C.
Gonçalves I; Ares MP; Moberg A; Moses J; To F; Montan J; Pedro LM; Dias N; Fernandes E Fernandes J; Fredrikson GN; Nilsson J; Jovinge S; Bengtsson E
J Vasc Res; 2008; 45(5):395-401. PubMed ID: 18376131
[TBL] [Abstract][Full Text] [Related]
11. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice.
van Vlijmen BJ; Gerritsen G; Franken AL; Boesten LS; Kockx MM; Gijbels MJ; Vierboom MP; van Eck M; van De Water B; van Berkel TJ; Havekes LM
Circ Res; 2001 Apr; 88(8):780-6. PubMed ID: 11325869
[TBL] [Abstract][Full Text] [Related]
12. Neointimal formation in two apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.
Shi W; Pei H; Fischer JJ; James JC; Angle JF; Matsumoto AH; Helm GA; Sarembock IJ
J Lipid Res; 2004 Nov; 45(11):2008-14. PubMed ID: 15314103
[TBL] [Abstract][Full Text] [Related]
13. rd1 Mouse retina shows an imbalance in the activity of cysteine protease cathepsins and their endogenous inhibitor cystatin C.
Ahuja S; Ahuja-Jensen P; Johnson LE; Caffé AR; Abrahamson M; Ekström PA; van Veen T
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1089-96. PubMed ID: 18326735
[TBL] [Abstract][Full Text] [Related]
14. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.
Shah PK; Yano J; Reyes O; Chyu KY; Kaul S; Bisgaier CL; Drake S; Cercek B
Circulation; 2001 Jun; 103(25):3047-50. PubMed ID: 11425766
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice.
Brånén L; Hovgaard L; Nitulescu M; Bengtsson E; Nilsson J; Jovinge S
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2137-42. PubMed ID: 15345516
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal cysteine proteases in atherosclerosis.
Liu J; Sukhova GK; Sun JS; Xu WH; Libby P; Shi GP
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1359-66. PubMed ID: 15178558
[TBL] [Abstract][Full Text] [Related]
17. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene.
Huh CG; Håkansson K; Nathanson CM; Thorgeirsson UP; Jonsson N; Grubb A; Abrahamson M; Karlsson S
Mol Pathol; 1999 Dec; 52(6):332-40. PubMed ID: 10748866
[TBL] [Abstract][Full Text] [Related]
18. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
19. Mixed allogeneic chimerism with wild-type strains ameliorates atherosclerosis in apolipoprotein E-deficient mice.
Ishimori N; Iwabuchi K; Fujii S; Watano K; Iwabuchi C; Ato M; Chiba H; Tanaka S; Kitabatake A; Onoé K
J Leukoc Biol; 2001 May; 69(5):732-40. PubMed ID: 11358981
[TBL] [Abstract][Full Text] [Related]
20. Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis.
Li W; Sultana N; Siraj N; Ward LJ; Pawlik M; Levy E; Jovinge S; Bengtsson E; Yuan XM
J Cell Mol Med; 2016 Sep; 20(9):1664-72. PubMed ID: 27079462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
